BR9407414A - Compositions containing a non-steroidal propionic acid anti-inflammatory agent amino acid salt and at least one decongestant an expectorant an antihistamine and an antitussive - Google Patents

Compositions containing a non-steroidal propionic acid anti-inflammatory agent amino acid salt and at least one decongestant an expectorant an antihistamine and an antitussive

Info

Publication number
BR9407414A
BR9407414A BR9407414A BR9407414A BR9407414A BR 9407414 A BR9407414 A BR 9407414A BR 9407414 A BR9407414 A BR 9407414A BR 9407414 A BR9407414 A BR 9407414A BR 9407414 A BR9407414 A BR 9407414A
Authority
BR
Brazil
Prior art keywords
decongestant
antitussive
expectorant
antihistamine
steroidal
Prior art date
Application number
BR9407414A
Other languages
Portuguese (pt)
Inventor
Sekhar Mitra
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9407414A publication Critical patent/BR9407414A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9407414A 1993-09-07 1994-08-24 Compositions containing a non-steroidal propionic acid anti-inflammatory agent amino acid salt and at least one decongestant an expectorant an antihistamine and an antitussive BR9407414A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11692793A 1993-09-07 1993-09-07
PCT/US1994/009581 WO1995007103A1 (en) 1993-09-07 1994-08-24 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive

Publications (1)

Publication Number Publication Date
BR9407414A true BR9407414A (en) 1996-11-12

Family

ID=22370083

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9407414A BR9407414A (en) 1993-09-07 1994-08-24 Compositions containing a non-steroidal propionic acid anti-inflammatory agent amino acid salt and at least one decongestant an expectorant an antihistamine and an antitussive

Country Status (7)

Country Link
EP (1) EP0719156A1 (en)
JP (1) JPH09502201A (en)
CN (1) CN1130354A (en)
AU (1) AU7604094A (en)
BR (1) BR9407414A (en)
CA (1) CA2170488A1 (en)
WO (1) WO1995007103A1 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626831A (en) * 1995-12-20 1997-05-06 Van Moerkerken; Arthur Method for relief and prevention of common cold, and compositions
US6469009B1 (en) * 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
ATE299699T1 (en) * 1996-05-20 2005-08-15 Searle Llc MEDICINAL PRODUCTS CONTAINING OXAPROZIN SODIUM SALT, POTASSIUM SALT, OR TRIS(HYDROXYMETHYL)AMINOMETHANE SALT
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
WO1998030228A1 (en) * 1997-01-13 1998-07-16 Emory University Compounds and their combinations for the treatment of influenza infection
HUP9700654A2 (en) * 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
BR9809022A (en) * 1997-04-30 2000-08-01 Warner Lambert Co Topical nasal anti-inflammatory compositions
CN1278728A (en) * 1997-09-19 2001-01-03 普罗克特和甘保尔公司 Compositions and methods for treating respiratory disorders
JP2002510336A (en) 1998-04-11 2002-04-02 エレカッパ・ユウロテラピッチ・ソシエタ・ペル・アチオニ Pharmaceutical preparations containing water-soluble ketoprofen salts and methods of using the same
IT1303671B1 (en) 1998-07-28 2001-02-23 Nicox Sa SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM
MXPA01001969A (en) * 1998-08-25 2002-04-24 Platt Chris Timed release tablet comprising naproxen and pseudoephedrine.
WO2000012071A2 (en) * 1998-08-29 2000-03-09 Miklos Ghyczy Pharmaceutical and/or diet product
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
PA8500101A1 (en) * 2000-03-30 2002-09-17 Schering Corp COMPOSITIONS AND METHODS TO TREAT ALLERGIC AND INFLAMMATORY CONDITIONS WITH YOU
PT1283043E (en) * 2000-05-17 2008-02-07 Senju Pharma Co Ophthalmic solution
PA8517201A1 (en) * 2000-05-25 2002-08-26 Schering Corp STABLE LIQUID ANTIHISTAMINIC ANTIHISTAMINIC PHARMACEUTICAL COMPOSITIONS
WO2003000264A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
NZ532019A (en) * 2001-09-04 2007-04-27 Boehringer Ingelheim Int Anti-influenza drugs
JP4549618B2 (en) * 2001-11-22 2010-09-22 第一三共ヘルスケア株式会社 Composition for rhinitis
ES2189682B1 (en) * 2001-12-11 2004-04-01 Laboratorios Del Dr. Esteve, S.A. DRINKABLE PREPARATION UNDERSTANDING KETOPROPHEN AND ITS EMPLOYMENT IN THE PROCESSING OF PROCESSES PROCESSING WITH FEVER, INFLAMMATION AND / OR PAIN, IN AN ANIMAL COLLECTIVE, SIMULTANEOUSLY.
JP4695326B2 (en) * 2001-12-21 2011-06-08 第一三共ヘルスケア株式会社 Pharmaceutical composition for rhinitis
JP4614638B2 (en) * 2002-06-07 2011-01-19 第一三共株式会社 Analgesic composition
JP4614640B2 (en) * 2002-07-04 2011-01-19 第一三共株式会社 Antipyretic composition
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
US7863287B2 (en) * 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
US6979689B2 (en) 2002-12-20 2005-12-27 Pediamed Pharmaceuticals, Inc. Compositions and methods for treating upper respiratory congestion
DE10332487A1 (en) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of chronic nociceptive pain
FR2865648B1 (en) * 2004-02-03 2006-06-30 Philippe Perovitch METHOD FOR DIFFUSION OF INSOLUBLE MOLECULES IN AQUEOUS MEDIUM AND COMPOSITION IMPLEMENTING SAID METHOD
US20050192355A1 (en) * 2004-02-17 2005-09-01 Wyeth Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines
CN1323662C (en) * 2004-06-18 2007-07-04 江苏恒瑞医药股份有限公司 Pharmaceutical composition containing ambroxol and erdosteine or acetylcysteine and application thereof
WO2005123052A1 (en) * 2004-06-18 2005-12-29 Jiangsu Hengrui Medicine Co., Ltd. Drug composition containing ambroxol and erdosteine or acetylcysteine
DE102004040630A1 (en) * 2004-08-21 2006-03-09 Balaban, Romulus, Dr.med. Combination therapy with procaine
RU2286770C2 (en) * 2004-11-22 2006-11-10 Закрытое акционерное общество "Научно-производственное объединение "Антивирал" (ЗАО "НПО "Антивирал") Anti-influenza agent
EP1721602A1 (en) * 2005-05-11 2006-11-15 The Jordanian Pharmaceutical Manufacturing Co. Controlled release oral drug delivery system
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
JP2009007332A (en) * 2007-05-25 2009-01-15 Daiichi Sankyo Healthcare Co Ltd Pharmaceutical composition containing azelastines and ephedorines
CN101544572B (en) * 2008-03-26 2013-03-20 连云港恒邦医药科技有限公司 Ambroxol derivative and method for preparing same
ES2338972B1 (en) * 2008-10-01 2011-03-10 Farmalider, S.A. PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND CODEINA LIQUID FOR ADMINISTRATION BY ORAL ROUTE, ITS PROCEDURE FOR PREPARATION AND USE OF THE SAME.
ES2350670B1 (en) * 2009-06-10 2011-12-07 Polichem, S.L. KETOPROPHENE VETERINARY COMPOSITION
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0919893D0 (en) * 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0921805D0 (en) * 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
PT2493465E (en) 2009-10-26 2014-12-22 Sephoris Pharmaceuticals Llc Treatment of sunburn using analgesics and antihistamines
CA2690488C (en) 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
GB2490840B (en) * 2010-03-01 2017-06-07 Farmalider Sa Liquid ibuprofen/codeine pharmaceutical composition for oral administration, the method for preparation thereof and use thereof
CN103446587A (en) * 2011-12-28 2013-12-18 汪明 Application of mastocyte inhibitor in preparation of medicine for resisting influenza virus infection
BR112019005224A2 (en) 2016-09-26 2019-06-11 Procter & Gamble dosage form for prolonged relief
CA3199168A1 (en) * 2020-12-04 2022-06-09 Laboratorios Silanes S.A. De C.V. Pharmaceutical composition of an analgaesic and an antihistamine forthe treatment of respiratory diseases
CN118125916A (en) * 2022-09-23 2024-06-04 南京知和医药科技有限公司 S- (+) -flurbiprofen salt and preparation method, pharmaceutical composition and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
WO1992017171A1 (en) * 1991-04-01 1992-10-15 Merck & Co., Inc. Ibuprofen-decongestant combinations

Also Published As

Publication number Publication date
JPH09502201A (en) 1997-03-04
CN1130354A (en) 1996-09-04
AU7604094A (en) 1995-03-27
EP0719156A1 (en) 1996-07-03
WO1995007103A1 (en) 1995-03-16
CA2170488A1 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
BR9407414A (en) Compositions containing a non-steroidal propionic acid anti-inflammatory agent amino acid salt and at least one decongestant an expectorant an antihistamine and an antitussive
US4552899B1 (en)
BR1100329A (en) Compound and pharmaceutical formulation
ITMI922400A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN
EP0630239A4 (en) Antipyretic and analgesic methods and compositions containing optically pure r(-) ketoprofen.
ATE128355T1 (en) COUGH/COLD MIXTURES CONTAINING NON-SEDATING ANTHISTAMINICS.
KR100334973B1 (en) Topical composition containing hyaluronic acid and NSAID
FI954767A (en) Lopophilic drugs containing pharmaceutical composition
ITMI920074A0 (en) OPHTHALMIC PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYLCISTEINE AND POLYVINYL ALCOHOL
SG67283A1 (en) Sulphonic acid esters radiation-sensitive mixtures made therewith and their use
BR9407306A (en) Pharmaceutical composition for oral administration and process for preparing the same
ITMI913170A0 (en) PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE CONTAINING A NON-STEROID ANTI-INFLAMMATORY AND A DECONGESTANT AS ACTIVE INGREDIENTS
BR9607095A (en) Compound pharmaceutical composition and processes for making and administering a compound
ITBO920183A0 (en) PHARMACEUTICAL COMPOSITION BASED ON BILE ACIDS IN MICROGRANULES WITH CONTROLLED RELEASE
NO20016068D0 (en) Use of oxypurine nucleosides for the preparation of a pharmaceutical composition for reducing inflammation in an animal
IL108327A (en) Pharmaceutical composition comprising 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent
DE3373275D1 (en) Anti-inflammatory/analgesic combination of alpha-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (nsaid)
BR9407415A (en) Compositions containing a non-steroidal anti-inflammatory agent amino acid salt of propionic acid and caffeine
PT100967A (en) METHOD AND DEVICE FOR TRANSDERMICALLY ADMINISTERING A THERMALLY STABLE DRUG
DE69328067D1 (en) Anti-inflammatory and analgesic diclofenac gel
DE4294862T1 (en) Pharmaceutical composition
EP0617956A3 (en) Anti-inflammatory analgesic plaster containing Piroxicam.
DE69434210D1 (en) PHARMACEUTICAL ANTACID COMPOSITION
AU7001796A (en) Benzoic acid compounds and medicinal use thereof
IS3984A (en) Method of preparation of a pharmaceutical composition intended for topical treatment of arthritis and its use

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal